Ignyta's Combo Drug/Diagnostics Strategy a Differentiator
By Marie Powers
Friday, July 19, 2013
A small biotech buy earlier this year could someday reap big rewards for Ignyta Inc., a San Diego firm that is integrating targeted drug discovery and development with companion diagnostics for patient stratification.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.